Overview
- 70 inspections across 67 sites are on record.
- 51 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-29.
At a glance
Inspections
70
Sites
67
Observations
51
Career since
Nov 2018
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Northland Nuclear Medicine, LLC | 29 May 2026 | Human Drugs | View 483 → |
| LEC Custom Products, Inc | 1 May 2026 | Human Drugs | |
| Rosemont Pharmaceuticals Ltd. | 24 Apr 2026 | Human Drugs | |
| Dechra Ltd | 17 Apr 2026 | Animal Drugs & Feeds | |
| Veterinary Pharmacy Corporation | 19 Mar 2026 | Animal Drugs & Feeds | View 483 → |
Sites inspected
Northland Nuclear Medicine, LLCBismarck, United States1 insp.
LEC Custom Products, IncMississauga, Canada1 insp.
Rosemont Pharmaceuticals Ltd.Leeds, United Kingdom1 insp.
Dechra LtdSkipton, United Kingdom1 insp.
Veterinary Pharmacy CorporationSaint Peter, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Travis V Hull3 shared
Tyler M Peterson3 shared
Lori B Wikstrom3 shared
JeanClaude Garay2 shared
Nibin Varghese2 shared
Sandra A Boyd2 shared
Santos E Camara2 shared
Andrew J Barrowcliff2 shared
Michele L Glendenning2 shared
Beatrix D Hippe1 shared
Full investigator report
Get the verbatim findings behind Vaishali J Patel's 51 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site